Gene: ERRFI1
Official Full Name: ERBB receptor feedback inhibitor 1provided by HGNC
Gene Summary: ERRFI1 is a cytoplasmic protein whose expression is upregulated with cell growth (Wick et al., 1995 [PubMed 7641805]). It shares significant homology with the protein product of rat gene-33, which is induced during cell stress and mediates cell signaling (Makkinje et al., 2000 [PubMed 10749885]; Fiorentino et al., 2000 [PubMed 11003669]).[supplied by OMIM, Mar 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO21820 | ERRFI1 Knockout cell line (HeLa) | Human | ERRFI1 | 1:3~1:6 | Negative | Online Inquiry |
KO21821 | ERRFI1 Knockout cell line (HCT 116) | Human | ERRFI1 | 1:2~1:4 | Negative | Online Inquiry |
KO21822 | ERRFI1 Knockout cell line (HEK293) | Human | ERRFI1 | 1:3~1:6 | Negative | Online Inquiry |
KO21823 | ERRFI1 Knockout cell line (A549) | Human | ERRFI1 | 1:3~1:4 | Negative | Online Inquiry |
ERRFI1 Gene Knockout Cell Lines are specialized cellular models that have undergone targeted mutagenesis to disrupt the expression of the ERRFI1 gene, also known as the ERBB receptor feedback inhibitor 1. This gene encodes a protein that plays a crucial role in the negative regulation of receptor tyrosine kinases (RTKs) such as EGFR, hence contributing to the modulation of signaling pathways involved in cell proliferation, differentiation, and survival. By producing these knockout cell lines, researchers can effectively study the downstream effects of ERRFI1 loss, providing insights into cancer biology and other diseases characterized by aberrant RTK signaling.
The primary function of ERRFI1 knockout cell lines lies in their ability to mimic pathological conditions wherein ERRFI1 activity is diminished or absent, allowing for the investigation of its contribution to various signaling pathways. This model can facilitate studies on cellular responses such as increased cell growth or resistance to anti-cancer therapies, through mechanisms that include altered apoptotic signaling and enhanced sensitivity to pro-tumorigenic factors.
Scientifically, these cell lines are invaluable tools in both basic and applied research settings, particularly in cancer studies. They can be utilized in drug discovery and development, tumor microenvironment assessments, and the evaluation of targeted therapies. The specific advantage of using ERRFI1 knockout models over wild-type counterparts lies in achieving a more precise understanding of ERBB family modulation, leading to more targeted and effective therapeutic strategies.
Compared to alternative models, our ERRFI1 Gene Knockout Cell Lines are developed with high specificity and reproducibility, ensuring that researchers can rely on consistent and biologically relevant data. This fidelity is further enhanced by our commitment to rigorous quality control standards in gene editing techniques.
For researchers and clinicians, the value of ERRFI1 Gene Knockout Cell Lines cannot be overstated. They represent a critical asset for unlocking the complexities of RTK signaling in various diseases, aiding in the identification of novel therapeutic targets and fostering the advancement of personalized medicine.
With extensive expertise in genetic engineering and cell line development, our company is dedicated to providing high-quality biological research tools that empower scientists to break new ground in their research endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.